UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant Chemotherapy: Increasing Relevance in Cancer Management

Maurie M. Markman

2013

Volltextzugriff (PDF)

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer : Current Knowledge and Future Challenges

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-20

2010

Volltextzugriff (PDF)

Targeting the EGF Receptor for Ovarian Cancer Therapy

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-11

2010

Volltextzugriff (PDF)

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-7

2010

Volltextzugriff (PDF)

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-13

2010

Volltextzugriff (PDF)

A Current Review of Targeted Therapeutics for Ovarian Cancer

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-11

2010

Volltextzugriff (PDF)

Repeated Intraperitoneal α-Radioimmunotherapy of Ovarian Cancer in Mice

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-5

2010

Volltextzugriff (PDF)

Downregulation of Epidermal Growth Factor Receptor Expression Contributes to α-TEA's Proapoptotic Effects in Human Ovarian Cancer Cell Lines

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-11

2010

Volltextzugriff (PDF)

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-9

2010

Volltextzugriff (PDF)

Antivascular Therapy for Epithelial Ovarian Cancer

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-16

2010

Volltextzugriff (PDF)

Disrupting Ovarian Cancer Metastatic Colonization : Insights from Metastasis Suppressor Studies

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-7

2010

Volltextzugriff (PDF)

The remarkable “paclitaxel story”: How many chapters remain to be written?

Gynecologic oncology, 2008-10, Vol.111 (1), p.7-8

Markman, Maurie, MD

2008

Volltextzugriff (PDF)

Epithelial Ovarian Cancer : Focus on Targeted Therapy

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-1

2010

Volltextzugriff (PDF)

Clinical Features of Hypersensitivity Reactions to Carboplatin

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1141-1145

1999

Volltextzugriff (PDF)

Society of Gynecologic Oncologists Position Paper: Breast Cancer Care

Gynecologic oncology, 2008-07, Vol.110 (1), p.7-12

2008

Volltextzugriff (PDF)

Nutritional Intervention in Ovarian Cancer: Failure to Appreciate the Fundamental Distinction Between a Prognostic and a Predictive Clinical Parameter

Clinical ovarian cancer and other gynecologic malignancies, 2010-05, Vol.3 (1), p.7-8

Markman, Maurie, MD

2010

Volltextzugriff (PDF)

Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy

Gynecologic oncology, 1991, Vol.40 (1), p.17-20

1991

Volltextzugriff (PDF)

Intraperitoneal antineoplastic drug delivery: rationale and results

The lancet oncology, 2003-05, Vol.4 (5), p.277-283

Markman, Maurie

2003

Volltextzugriff (PDF)

Cardio-Oncology: mechanisms of cardiovascular toxicity [version 1; peer review: 2 approved]

F1000 research, 2018, Vol.7, p.113-113

2018

Volltextzugriff (PDF)

Ovarian cancer

The Lancet (British edition), 2009-10, Vol.374 (9698), p.1371-1382

2009

Volltextzugriff (PDF)

Cardio-oncology: management of cardiovascular toxicity [version 1; peer review: 2 approved]

F1000 research, 2019, Vol.8, p.120

2019

Volltextzugriff (PDF)

Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial Design

Journal of clinical oncology, 2004-08, Vol.22 (15), p.3120-3125

2004

Volltextzugriff (PDF)

Managing taxane toxicities

Supportive care in cancer, 2003-03, Vol.11 (3), p.144-147

MARKMAN, Maurie

2003

Volltextzugriff (PDF)

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Journal of clinical oncology, 2010-08, Vol.28 (22), p.3570-3576

2010

Volltextzugriff (PDF)

Safety Issues in Using Complementary and Alternative Medicine

Journal of clinical oncology, 2002-09, Vol.20 (suppl 1), p.39s-41s

MARKMAN, Maurie

2002

Volltextzugriff (PDF)

1 – 25 von 630

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(410)
Mit Volltextzugriff
(589)

Publikationsform

Artikel
(425)
Buchkapitel
(193)
Bücher
(7)
Berichte
(5)

Sprache

Englisch
(630)

Erscheinungsjahr

n.n

Thema

Science & Technology
(505)
Life Sciences & Biomedicine
(502)
Oncology
(454)
Humans
(365)
Female
(270)
Biological And Medical Sciences
(161)
Medical Sciences
(160)
Middle Aged
(143)
Ovarian Neoplasms - Drug Therapy
(142)
Aged
(123)
Obstetrics & Gynecology
(115)
Pharmacology. Drug Treatments
(110)
Chemotherapy
(107)
Adult
(99)
Antineoplastic Agents
(89)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(80)
Ovarian Cancer
(63)
Tumors
(58)
Cisplatin - Administration & Dosage
(51)
Antineoplastic Agents - Administration & Dosage
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant Chemotherapy: Increasing Relevance in Cancer Management

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer : Current Knowledge and Future Challenges

Targeting the EGF Receptor for Ovarian Cancer Therapy

Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma

The Role of Dysregulated Glucose Metabolism in Epithelial Ovarian Cancer

A Current Review of Targeted Therapeutics for Ovarian Cancer

Repeated Intraperitoneal α-Radioimmunotherapy of Ovarian Cancer in Mice

Downregulation of Epidermal Growth Factor Receptor Expression Contributes to α-TEA's Proapoptotic Effects in Human Ovarian Cancer Cell Lines

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

Antivascular Therapy for Epithelial Ovarian Cancer

Disrupting Ovarian Cancer Metastatic Colonization : Insights from Metastasis Suppressor Studies

The remarkable “paclitaxel story”: How many chapters remain to be written?

Epithelial Ovarian Cancer : Focus on Targeted Therapy

Clinical Features of Hypersensitivity Reactions to Carboplatin

Society of Gynecologic Oncologists Position Paper: Breast Cancer Care

Nutritional Intervention in Ovarian Cancer: Failure to Appreciate the Fundamental Distinction Between a Prognostic and a Predictive Clinical Parameter

Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy

Intraperitoneal antineoplastic drug delivery: rationale and results

Cardio-Oncology: mechanisms of cardiovascular toxicity [version 1; peer review: 2 approved]

Ovarian cancer

Cardio-oncology: management of cardiovascular toxicity [version 1; peer review: 2 approved]

Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial Design

Managing taxane toxicities

Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer

Safety Issues in Using Complementary and Alternative Medicine

Suchergebnisse filtern